MSCs, often reprogrammed in tumors, may secrete immunosuppressive factors such as IL-10 and TGF-β, with EVs potentially enhancing this effect by delivering specific miRNAs or proteins that boost MSC immunosuppressive functions, thus facilitating tumor immune evasion (102). This evidence concerns the gene IL10 and neoplasm.